Brief: Lipigon Q3 Operating Loss Widens To SEK 11.5 Mln

Lipigon Pharmaceuticals AB

24/11/2021 08:12

Nov 24 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * Q3 NET SALES SEK 0.6 MILLION VERSUS SEK 2.0 MILLION YEAR
AGO
    * Q3 OPERATING LOSS SEK 11.5 MILLION VERSUS LOSS SEK 0.7
MILLION
YEAR AGO

Source text for Eikon:  ID:nBQN5JVgQm 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))